Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine

Cancer Statistics, 2006

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth M. Ward et al. · CA A Cancer Journal for Clinicians · 2006 · 5.3K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

Arindam Bhattacharjee, William G. Richards, Jane Staunton et al. · Proceedings of the National Academy of Sciences · 2001 · 2.6K citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Gene-expression profiles predict survival of patients with lung adenocarcinoma

David G. Beer, Sharon L. R. Kardia, Chiang‐Ching Huang et al. · Nature Medicine · 2002 · 2.1K citations

Life Sciences, Molecular Biology, Oncology +14

Aberrant methylation of <i>p16</i> ^INK4a is an early event in lung cancer and a potential biomarker for early diagnosis

Steven A. Belinsky, Kristen J. Nikula, William A. Palmisano et al. · Proceedings of the National Academy of Sciences · 1998 · 962 citations · Full text

Medicine, Genetics, Molecular Biology +17

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.

Manel Esteller, Montse Sánchez‐Céspedes, Rafael Rosell et al. · PubMed · 1999 · 928 citations

Medicine, Molecular Biology, Oncology +17